• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2014 - 2020年参保队列中与阿片类药物相关的急诊科就诊后接受丁丙诺啡治疗的趋势及差异

Trends and Disparities in Access to Buprenorphine Treatment Following an Opioid-Related Emergency Department Visit Among an Insured Cohort, 2014-2020.

作者信息

Stevens Maria A, Tsai Jennifer, Savitz Samuel T, Nath Bidisha, Melnick Edward R, D'Onofrio Gail, Jeffery Molly Moore

机构信息

Department of Health Care Policy Research, Mayo Clinic, Rochester, Minnesota.

Department of Health Policy and Management, University of North Carolina at Chapel Hill.

出版信息

JAMA Netw Open. 2022 Jun 1;5(6):e2215287. doi: 10.1001/jamanetworkopen.2022.15287.

DOI:10.1001/jamanetworkopen.2022.15287
PMID:35657629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9166266/
Abstract

This cross-sectional study examines trends in access to buprenorphine treatment following an opioid-related emergency department (ED) visit among adults with commercial or Medicare Advantage health insurance between 2014 and 2020.

摘要

这项横断面研究调查了2014年至2020年间，在因阿片类药物相关问题前往急诊科就诊的成年商业保险或医疗保险优势计划参保者中，丁丙诺啡治疗的可及性趋势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8ed/9166266/4c3122ee6131/jamanetwopen-e2215287-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8ed/9166266/4c3122ee6131/jamanetwopen-e2215287-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8ed/9166266/4c3122ee6131/jamanetwopen-e2215287-g001.jpg

相似文献

1
Trends and Disparities in Access to Buprenorphine Treatment Following an Opioid-Related Emergency Department Visit Among an Insured Cohort, 2014-2020.2014 - 2020年参保队列中与阿片类药物相关的急诊科就诊后接受丁丙诺啡治疗的趋势及差异
JAMA Netw Open. 2022 Jun 1;5(6):e2215287. doi: 10.1001/jamanetworkopen.2022.15287.
2
Trends and Disparities in Initiation of Buprenorphine in US Emergency Departments, 2013-2022.2013 - 2022年美国急诊科丁丙诺啡起始治疗的趋势与差异
JAMA Netw Open. 2024 Sep 3;7(9):e2435603. doi: 10.1001/jamanetworkopen.2024.35603.
3
Being Part of the Solution: Initiating Medication-Assisted Treatment in the Emergency Department.作为解决方案的一部分：在急诊科启动药物辅助治疗。
Adv Emerg Nurs J. 2022;44(2):158-166. doi: 10.1097/TME.0000000000000407.
4
As Overdoses Climb, Emergency Departments Begin Treating Opioid Use Disorder.随着过量用药情况攀升，急诊科开始治疗阿片类药物使用障碍。
JAMA. 2018 Jun 5;319(21):2158-2160. doi: 10.1001/jama.2018.4648.
5
Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study.美沙酮使用与阿片类药物使用障碍急诊患者获得途径的差异：一项横断面研究。
J Subst Abuse Treat. 2021 Nov;130:108405. doi: 10.1016/j.jsat.2021.108405. Epub 2021 Apr 20.
6
Emerging Trends in Opioid Use Disorder Management: A 6-Year Analysis of Emergency Department Visits, Buprenorphine Prescriptions, and Naloxone Distribution (2016-2021).阿片类物质使用障碍管理的新趋势：对急诊科就诊、丁丙诺啡处方和纳洛酮分发的6年分析（2016 - 2021年）
Prim Care Companion CNS Disord. 2024 Apr 2;26(2):23br03659. doi: 10.4088/PCC.23br03659.
7
Early emergency department experience with 7-day extended-release injectable buprenorphine for opioid use disorder.早期在急诊部门使用 7 天长效缓释丁丙诺啡治疗阿片类药物使用障碍的经验。
Acad Emerg Med. 2023 Dec;30(12):1264-1271. doi: 10.1111/acem.14782. Epub 2023 Aug 22.
8
Buprenorphine Out-of-Pocket Costs and Discontinuation in Privately Insured Adults With Opioid Use Disorder.丁丙诺啡自付费用与患有阿片类物质使用障碍的私人保险成年人停药情况
JAMA Intern Med. 2023 Sep 1;183(9):1023-1026. doi: 10.1001/jamainternmed.2023.2826.
9
In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence.简而言之：丁丙诺啡/纳洛酮（Zubsolv）用于治疗阿片类药物依赖。
Med Lett Drugs Ther. 2013 Oct 14;55(1427):83.
10
Emergency Department Initiation of Buprenorphine for Opioid Use Disorder: Current Status, and Future Potential.急诊科阿片类药物使用障碍丁丙诺啡的应用：现状和未来潜力。
CNS Drugs. 2019 Dec;33(12):1147-1154. doi: 10.1007/s40263-019-00667-7.

引用本文的文献

1
Adaptive decision support for addiction treatment to implement initiation of buprenorphine for opioid use disorder in the emergency department: protocol for the ADAPT Multiphase Optimization Strategy trial.用于成瘾治疗的适应性决策支持，以在急诊科启动丁丙诺啡治疗阿片类物质使用障碍：ADAPT多阶段优化策略试验方案
BMJ Open. 2025 Feb 20;15(2):e098072. doi: 10.1136/bmjopen-2024-098072.
2
Emergency Clinician Buprenorphine Initiation, Subsequent Prescriptions, and Continuous Prescriptions.急诊临床医生启动丁丙诺啡治疗、后续处方及连续处方
JAMA. 2025 Apr 8;333(14):1232-1241. doi: 10.1001/jama.2024.27976.
3
Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements.

本文引用的文献

1
Naloxone and Buprenorphine Prescribing Following US Emergency Department Visits for Suspected Opioid Overdose: August 2019 to April 2021.纳洛酮和丁丙诺啡处方后，美国急诊疑似阿片类药物过量：2019 年 8 月至 2021 年 4 月。
Ann Emerg Med. 2022 Mar;79(3):225-236. doi: 10.1016/j.annemergmed.2021.10.005. Epub 2021 Nov 19.
2
Trends in the Use of Buprenorphine in US Emergency Departments, 2002-2017.2002-2017 年美国急诊科丁丙诺啡使用趋势。
JAMA Netw Open. 2020 Oct 1;3(10):e2021209. doi: 10.1001/jamanetworkopen.2020.21209.
3
Incidence of Treatment for Opioid Use Disorder Following Nonfatal Overdose in Commercially Insured Patients.
放松 X 豁免培训要求后丁丙诺啡的处方特征。
JAMA Netw Open. 2024 Aug 1;7(8):e2425999. doi: 10.1001/jamanetworkopen.2024.25999.
4
Variability in Practice of Buprenorphine Treatment by Emergency Department Operational Characteristics.急诊部门运作特点对丁丙诺啡治疗实践的变异性。
West J Emerg Med. 2024 Jul;25(4):483-489. doi: 10.5811/westjem.18019.
5
Digital health interventions to support women with opioid use disorder: A scoping review.支持患有阿片类物质使用障碍的女性的数字健康干预措施：一项范围综述。
Drug Alcohol Depend. 2024 Aug 1;261:111352. doi: 10.1016/j.drugalcdep.2024.111352. Epub 2024 Jun 2.
6
Trends in the Prescribing of Buprenorphine for Opioid Use Disorder, 2019-2023.2019 - 2023年用于阿片类物质使用障碍的丁丙诺啡处方趋势
Mayo Clin Proc Innov Qual Outcomes. 2024 May 24;8(3):308-320. doi: 10.1016/j.mayocpiqo.2024.04.004. eCollection 2024 Jun.
7
Racial and ethnic disparities in emergency department-initiated buprenorphine across five health care systems.五个医疗系统中急诊室开具丁丙诺啡的种族和民族差异。
Acad Emerg Med. 2023 Jul;30(7):709-720. doi: 10.1111/acem.14668. Epub 2023 Feb 27.
商业保险患者非致死性药物过量后治疗阿片类药物使用障碍的发生率。
JAMA Netw Open. 2020 May 1;3(5):e205852. doi: 10.1001/jamanetworkopen.2020.5852.
4
Emergency Departments - A 24/7/365 Option for Combating the Opioid Crisis.急诊科——应对阿片类药物危机的全年无休选择。
N Engl J Med. 2018 Dec 27;379(26):2487-2490. doi: 10.1056/NEJMp1811988.
5
Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.急诊科启动的丁丙诺啡/纳洛酮治疗阿片类药物依赖：一项随机临床试验。
JAMA. 2015 Apr 28;313(16):1636-44. doi: 10.1001/jama.2015.3474.